Parkinson's disease (PD) is a disabling neurodegenerative disease that manifests with
resting tremor, bradykinesia, rigidity and postural instability. Since the discovery of …

Parkinson's disease (PD) is a clinically common neurodegenerative disease of the central
nervous system (CNS) characterized by loss of dopamine neurons in the substantia nigra …

Parkinson's disease (PD) is the second-most common age-dependent neurodegenerative
disorder and is caused by severe degeneration of dopaminergic neurons in the substantia …

Despite the wide research going on in Parkinson's disease (PD), the burden of PD still
remains high and continues to increase. The current drugs available for the treatment of PD …

Parkinson's disease is the second most common neurodegenerative disease commonly
affecting the older population. Loss of dopaminergic neurons in the substantia nigra of brain …

Aberrant expression of microRNA (miRNA) in tissues may lead to altered level in circulation.
Considerable evidence has suggested that miRNA deregulation is involved in the …

Parkinson's disease (PD) is the most prevalent central nervous system (CNS) movement
disorder and the second most common neurodegenerative disease overall. PD is …

Parkinson's disease (PD) is an age associated neurological disorder which is specified by
cardinal motor symptoms such as tremor, stiffness, bradykinesia, postural instability, and non …

MicroRNAs (miRNAs) are post-transcriptional gene expression regulators, playing key roles
in neuronal development, plasticity and disease. Parkinson's disease (PD) is the second …

MicroRNAs are small non-protein coding RNAs that regulate gene expression through post-
transcriptional repression. Recent studies demonstrated the importance of microRNAs in the …